limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie,Belinda Phipson,Di Wu,Yifang Hu,Charity W. Law,Wei Shi,Gordon K. Smyth,Gordon K. Smyth +7 more
Reads0
Chats0
TLDR
The philosophy and design of the limma package is reviewed, summarizing both new and historical features, with an emphasis on recent enhancements and features that have not been previously described.Abstract:
limma is an R/Bioconductor software package that provides an integrated solution for analysing data from gene expression experiments. It contains rich features for handling complex experimental designs and for information borrowing to overcome the problem of small sample sizes. Over the past decade, limma has been a popular choice for gene discovery through differential expression analyses of microarray and high-throughput PCR data. The package contains particularly strong facilities for reading, normalizing and exploring such data. Recently, the capabilities of limma have been significantly expanded in two important directions. First, the package can now perform both differential expression and differential splicing analyses of RNA sequencing (RNA-seq) data. All the downstream analysis tools previously restricted to microarray data are now available for RNA-seq as well. These capabilities allow users to analyse both RNA-seq and microarray data with very similar pipelines. Second, the package is now able to go past the traditional gene-wise expression analyses in a variety of ways, analysing expression profiles in terms of co-regulated sets of genes or in terms of higher-order expression signatures. This provides enhanced possibilities for biological interpretation of gene expression differences. This article reviews the philosophy and design of the limma package, summarizing both new and historical features, with an emphasis on recent enhancements and features that have not been previously described.read more
Citations
More filters
Journal ArticleDOI
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
Karsten Krug,Eric J. Jaehnig,Shankha Satpathy,Lili Blumenberg,Alla Karpova,Meenakshi Anurag,George Miles,Philipp Mertins,Philipp Mertins,Yifat Geffen,Lauren C. Tang,Lauren C. Tang,David I. Heiman,Song Cao,Yosef E. Maruvka,Jonathan T. Lei,Chen Huang,Ramani B. Kothadia,Antonio Colaprico,Chet Birger,Jarey Wang,Yongchao Dou,Bo Wen,Zhiao Shi,Yuxing Liao,Maciej Wiznerowicz,Maciej Wiznerowicz,Matthew A. Wyczalkowski,Xi Steven Chen,Jacob J. Kennedy,Amanda G. Paulovich,Mathangi Thiagarajan,Christopher R. Kinsinger,Tara Hiltke,Emily S. Boja,Mehdi Mesri,Ana I. Robles,Henry Rodriguez,Thomas F. Westbrook,Li Ding,Gad Getz,Gad Getz,Karl R. Clauser,David Fenyö,Kelly V. Ruggles,Bing Zhang,D. R. Mani,Steven A. Carr,Matthew J. Ellis,Michael A. Gillette,Michael A. Gillette,Shayan C. Avanessian,Shuang Cai,Daniel W. Chan,Xian Chen,Nathan Edwards,Andrew N. Hoofnagle,M. Harry Kane,Karen A. Ketchum,Eric Kuhn,Douglas A. Levine,Shunqiang Li,Daniel C. Liebler,Tao Liu,Jingqin Luo,Subha Madhavan,Christopher G. Maher,Jason E. McDermott,Peter B. McGarvey,Mauricio Oberti,Akhilesh Pandey,Samuel H. Payne,David F. Ransohoff,Robert Rivers,Karin D. Rodland,Paul A. Rudnick,Melinda E. Sanders,Kenna M. Shaw,Ie Ming Shih,Robbert J.C. Slebos,Richard D. Smith,Michael Snyder,Stephen E. Stein,David L. Tabb,Ratna R. Thangudu,Stefani N. Thomas,Yue Wang,Forest M. White,Jeffrey R. Whiteaker,Gordon Whiteley,Hui Zhang,Zhen Zhang,Yingming Zhao,Heng Zhu,Lisa J. Zimmerman +94 more
TL;DR: The integration of mass spectrometry-based proteomics with next-generation DNA and RNA sequencing profiles tumors more comprehensively underscores the potential of proteogenomics for clinical investigation of breast cancer through more accurate annotation of targetable pathways and biological features of this remarkably heterogeneous malignancy.
Journal ArticleDOI
Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
Zichen Wang,Caroline D. Monteiro,Kathleen M. Jagodnik,Kathleen M. Jagodnik,Kathleen M. Jagodnik,Nicolas F. Fernandez,Gregory W. Gundersen,Andrew D. Rouillard,Sherry L. Jenkins,Axel S. Feldmann,Kevin Hu,Michael G. McDermott,Qiaonan Duan,Neil R. Clark,Matthew R. Jones,Yan Kou,Troy Goff,Holly Woodland,Fabio M R. Amaral,Gregory L. Szeto,Oliver Fuchs,Sophia Miryam Schüssler-Fiorenza Rose,Sophia Miryam Schüssler-Fiorenza Rose,Shvetank Sharma,Uwe Schwartz,Xabier Bengoetxea Bausela,Maciej Szymkiewicz,Vasileios Maroulis,Anton Salykin,Carolina M. Barra,Candice D. Kruth,Nicholas J. Bongio,Vaibhav Mathur,Radmila D. Todoric,Udi Rubin,Apostolos Malatras,Carl T. Fulp,John A. Galindo,Ruta Motiejunaite,Christoph Jüschke,Philip C. Dishuck,Katharina Lahl,Mohieddin Jafari,Sara Aibar,Apostolos Zaravinos,Apostolos Zaravinos,Linda H. Steenhuizen,Lindsey R. Allison,Pablo Gamallo,Fernando de Andres Segura,Tyler Dae Devlin,Vicente Perez-Garcia,Avi Ma'ayan +52 more
TL;DR: This article reported a crowdsourcing project to annotate and reanalyse a large number of gene expression profiles from Gene Expression Omnibus (GEO) through a massive open online course on Coursera, over 70 participants from over 25 countries identify and annotate 2,460 single-gene perturbation signatures, 839 disease versus normal signatures, and 906 drug perturbations signatures.
Journal ArticleDOI
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
Bruno Sangro,Ignacio Melero,Samir Wadhawan,Richard S. Finn,Ghassan K. Abou-Alfa,Ann-Lii Cheng,Thomas Yau,Junji Furuse,Joong-Won Park,Zachary Boyd,Hao Tracy Tang,Yun Shen,Marina Tschaika,Jaclyn Neely,Anthony B. El-Khoueiry +14 more
TL;DR: Retrospective analyses suggest that anti-tumour immune response may play a role in the treatment benefit of nivolumab in HCC, and biomarkers of inflammation, and inflammatory gene signatures trended with improved survival and response.
Journal ArticleDOI
Complementarity and redundancy of IL-22-producing innate lymphoid cells.
Lucille C. Rankin,Mathilde J. H. Girard-Madoux,Cyril Seillet,Cyril Seillet,Lisa A. Mielke,Lisa A. Mielke,Yann M. Kerdiles,Aurore Fenis,Elisabeth Wieduwild,Tracy L Putoczki,Tracy L Putoczki,Stanislas Mondot,Olivier Lantz,Dieter Demon,Anthony T. Papenfuss,Anthony T. Papenfuss,Gordon K. Smyth,Gordon K. Smyth,Mohamed Lamkanfi,Sebastian Carotta,Sebastian Carotta,Sebastian Carotta,Jean-Christophe Renauld,Wei Shi,Wei Shi,Sabrina Carpentier,Tim Soos,Christopher Arendt,Sophie Ugolini,Nicholas D. Huntington,Nicholas D. Huntington,Gabrielle T. Belz,Gabrielle T. Belz,Eric Vivier +33 more
TL;DR: The data show that interplay between intestinal ILC3 cells and adaptive lymphocytes results in robust complementary failsafe mechanisms that ensure gut homeostasis, and the transcriptional signature associated with the transcription factor T-bet–dependent differentiation of NCR− ILC2 cells into NCR+ I LC3 cells is identified.
Journal ArticleDOI
The plastisphere in marine ecosystem hosts potential specific microbial degraders including Alcanivorax borkumensis as a key player for the low-density polyethylene degradation
TL;DR: It is shown that the bacterial community composition is clearly plastic nature dependent and hydrocarbon-degrading bacteria such as Alcanivorax, Marinobacter and Arenibacter genera are enriched with LDPE and PET, implying that these bacteria are potential players in plastic degradation.
References
More filters
Journal Article
R: A language and environment for statistical computing.
TL;DR: Copyright (©) 1999–2012 R Foundation for Statistical Computing; permission is granted to make and distribute verbatim copies of this manual provided the copyright notice and permission notice are preserved on all copies.
Journal ArticleDOI
Controlling the false discovery rate: a practical and powerful approach to multiple testing
Yoav Benjamini,Yosef Hochberg +1 more
TL;DR: In this paper, a different approach to problems of multiple significance testing is presented, which calls for controlling the expected proportion of falsely rejected hypotheses -the false discovery rate, which is equivalent to the FWER when all hypotheses are true but is smaller otherwise.
Journal ArticleDOI
Statistical methods for assessing agreement between two methods of clinical measurement.
TL;DR: An alternative approach, based on graphical techniques and simple calculations, is described, together with the relation between this analysis and the assessment of repeatability.
Journal ArticleDOI
Gene Ontology: tool for the unification of biology
M Ashburner,Catherine A. Ball,Judith A. Blake,David Botstein,Heather Butler,J. M. Cherry,Allan Peter Davis,Kara Dolinski,Selina S. Dwight,J.T. Eppig,Midori A. Harris,David P. Hill,Laurie Issel-Tarver,Andrew Kasarskis,Suzanna E. Lewis,John C. Matese,Joel E. Richardson,M. Ringwald,Gerald M. Rubin,Gavin Sherlock +19 more
TL;DR: The goal of the Gene Ontology Consortium is to produce a dynamic, controlled vocabulary that can be applied to all eukaryotes even as knowledge of gene and protein roles in cells is accumulating and changing.
Journal ArticleDOI
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian,Pablo Tamayo,Vamsi K. Mootha,Sayan Mukherjee,Benjamin L. Ebert,Michael A. Gillette,Amanda G. Paulovich,Scott L. Pomeroy,Todd R. Golub,Eric S. Lander,Jill P. Mesirov +10 more
TL;DR: The Gene Set Enrichment Analysis (GSEA) method as discussed by the authors focuses on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation.